Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery

January 3, 2020 updated by: Göteborg University

Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery -a Randomized Controlled Trial

This study evaluates the effect of a training intervention after thoracoabdominal resection of the oesophagus. Half of the patients scheduled for thoracoabdominal oesophagus surgery were randomized to an intervention group while the other half a control group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It is well known that thoracoabdominal oesophageal resection for cancer is a procedure with high risks for complications. Earlier trials have shown that respiratory restrictions persist after the operation as well as lower physical function, range of motion in the rib-cage and limitations in activities in daily living. There are, however, only two clinical studies that evaluate postoperative breathing exercises and none evaluating any other rehabilitation interventions.

In other types of extensive surgery that may affect mobility with trauma to muscles and bone structures in the thorax and thoracic spinal column, there is strong evidence that speaks for an active rehabilitation approach in favour of a less active one.

The intervention evaluated was a rehabilitation program including exercises to restore lung function, range of motion in the thoracic spine and shoulders and strength exercises for the back extensors, shoulders and legs.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for thoracoabdominal oesophageal resection
  • Ability to perform 90 W during a sub-maximal bicycle test
  • Ability to speak Swedish

Exclusion Criteria:

  • Serious untreated cardiac disease that may be critical
  • Musculoskeletal or neurological disease or trauma affecting respiration or range of motion in the rib cage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training group
Training program: Daily exercises for 3 months

After 1 week

  • Chest expansions
  • Static thoracic extension in prone
  • Lateral flexion of the spine in standing
  • Bilateral shoulder flexion
  • Shoulder external rotation of shoulders
  • Rotation of the thoracic spine in sitting
  • Static back extensor strength in prone

After 1 month

  • Thoracic extension, rotation and flexion abduction
  • Hand in neck and in back
  • Bilateral active flexion abduction
  • Strength training of leg muscles
  • Static back extensor strength

After 2 months

  • Strength training of legs and back muscles
  • Push-ups against a wall
  • Thoracic extension in sitting and standing
  • Thoracic rotation in lying
  • Stretching of mm. pectoralis Training was performed daily with 10 rep of each exercise
No Intervention: Controls
Standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of physical disability estimated by the Disability Rating Index (DRI)
Time Frame: 3 months
12 items covering activities from dressing and going for walks to lifting heavy objects and exercising. The item responses were rated on visual analogue scales (0-100)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain in the neck, rib cage and shoulders (visual analogue scale)
Time Frame: 3 months
Estimated on a 100-mm visual analogue scale
3 months
FVC (Forced Vital Capacity)
Time Frame: 3 months
Forced Vital Capacity performed in a standardised manner
3 months
Range of motion
Time Frame: 3 months
Thorax expansion, back flexion, extension and lateral flexion, shoulder flexion and abduction
3 months
Physical function (Time stand test and heel rise test)
Time Frame: 3 months
Time stand test and heel rise test
3 months
Physical Activity (six-level scale)
Time Frame: 3 months
A six-level scale where low figures indicate a sedentary and a high score an active lifestyle according to Grimby et al
3 months
Quality of Life by EORTC QLQ-C30
Time Frame: 3 months
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core -30 version 3.0. All responses were converted to a score of between 0 and 100 using a linear transformation following EORTC guidelines (EORTC). High scores indicate good functioning but a high level of symptoms
3 months
FEV1 s
Time Frame: 3 months
Forced performed in a standardised manner
3 months
PEF (Peak Expiratory Flow)
Time Frame: 3 months
Peak Expiratory Flow performed in a standardised manner
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monika Fagevik Olsén, PhD, Professor at Sahlgrenska Academy at Gothenburg University, Sweden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2005

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

December 30, 2014

First Submitted That Met QC Criteria

January 9, 2015

First Posted (Estimate)

January 12, 2015

Study Record Updates

Last Update Posted (Actual)

January 6, 2020

Last Update Submitted That Met QC Criteria

January 3, 2020

Last Verified

January 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oesophagus Cancer

Clinical Trials on Training group

Subscribe